中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Epkinly
    Epkinly
    departments：肿瘤科
    drug：注射液
    Active：epcoritamab-bysp
    indication：在两行或更多次全身治疗后复发或难治性弥漫性大B细胞淋巴瘤（未另行说明）和高级B细胞淋巴瘤
    Licensor：Genmab US, Inc.
    Approved Country/Region：FDA
    Approval time：2023-05-19